Shanghai ZJ Bio-Tech Co (SHSE:688317) Cash And Cash Equivalents : ¥2,642.8 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai ZJ Bio-Tech Co Cash And Cash Equivalents?

Shanghai ZJ Bio-Tech Co's quarterly cash and cash equivalents increased from Sep. 2024 (¥2,744.48 Mil) to Dec. 2024 (¥2,783.39 Mil) but then stayed the same from Dec. 2024 (¥2,783.39 Mil) to Mar. 2025 (¥2,642.79 Mil).

Shanghai ZJ Bio-Tech Co's annual cash and cash equivalents declined from Dec. 2022 (¥3,147.72 Mil) to Dec. 2023 (¥2,769.50 Mil) but then increased from Dec. 2023 (¥2,769.50 Mil) to Dec. 2024 (¥2,783.39 Mil).

Shanghai ZJ Bio-Tech Co Cash And Cash Equivalents Historical Data

The historical data trend for Shanghai ZJ Bio-Tech Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai ZJ Bio-Tech Co Cash And Cash Equivalents Chart

Shanghai ZJ Bio-Tech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

1,204.71

2,935.93

3,147.72

2,769.50

2,783.39

Shanghai ZJ Bio-Tech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash And Cash Equivalents	Get a 7-Day Free Trial															2,760.52	2,765.56	2,744.48	2,783.39	2,642.79

Shanghai ZJ Bio-Tech Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Shanghai ZJ Bio-Tech Co (SHSE:688317) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Shanghai ZJ Bio-Tech Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Shanghai ZJ Bio-Tech Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai ZJ Bio-Tech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai ZJ Bio-Tech Co Ltd (SHSE:688317) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 588 Xinjun Ring Road, Building 26, Pujiang Hi-Tech Park, Caohejing Development Zone, Shanghai, CHN

Website

https://www.liferiver.com.cn

Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.

Executives

Ni Wei Qin	Directors, senior managers
Shao Jun Bin	Directors, senior managers, core technical personn
Zhu Qin Wei	Core technical personnel
Lv Li Lang	senior management

Shanghai ZJ Bio-Tech Co Headlines

No Headlines